Katalyze AI raises $10.5M to scale agentic pharma operating system

On July 6, 2026, Katalyze AI announced a $10.5 million seed round led by Bonfire Ventures, with participation from Inovia Capital, Ripple Ventures, Alumni Ventures and angel investors. The San Francisco–based startup builds an agentic operating system that lets pharma teams deploy AI agents to handle manufacturing, quality and engineering workflows, and says it is already used by 5 of the 20 largest global pharma companies.